INVO Fertility, Inc. (IVF) shareholders
Close on Nov 17, 2026Market cap $5.47MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Greenblock Capital, LLC Joint filing with Spencer Christopher J (9.99%) | 617,954 | 9.99% | 13G (passive) | Jun 25, 2025 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.99%) | 371,562 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Ashkan Mapar Joint filing with Alumni Capital LP (9.99%), Alumni Capital GP LLC (9.99%) | 272,249 | 9.99% | 13G (passive) | Aug 4, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IVF | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Virtu Financial LLC | 63,174 | 2.52% | $120.00K | New | 0.00% |
| Scientech Research LLC | 32,338 | 1.29% | $61.44K | New | 0.05% |
| StoneX Group Inc. | 15,702 | 0.63% | $29.82K | New | 0.00% |
| Susquehanna International Group, Llp | 11,463 | 0.46% | $21.78K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 8,155 | 0.33% | $15.49K | New | 0.00% |
| SBI Securities Co., Ltd. | 53 | 0.00% | $101 | +50 | 0.00% |
| Caitong International Asset Management Co., Ltd | 38 | 0.00% | $72 | New | 0.00% |
| Integrated Wealth Concepts LLC | 8 | 0.00% | $15 | New | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $2 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 5.2% | 8 / 1 | 0 / 6 | 0M | 0M |
| Q1 2026 | 7 | 0M | 7.7% | 4 / 2 | 0 / 6 | 0M | 0M |
| Q4 2025 | 9 | 0M | 2.1% | 9 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
2 funds held IVF in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of IVF | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 14,082 | 0.56% | $26.47K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -400 | -0.02% | -$760 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Steve Shum | Chief Executive Officer, Director | 674 | 0.03% | Oct 3, 2025 |
| Terah Renee Krigsvold | Chief Financial Officer | 1 | 0.00% | Jan 13, 2026 |
| Andrea Goren | Chief Financial Officer | 129,227 | 5.15% | Aug 28, 2025 |
| Matthew K. Szot | Director | 0 | – | Dec 5, 2025 |
| Trent D. Davis | Director | 49 | 0.00% | Aug 28, 2025 |
| Barbara Ryan | Director | 46 | 0.00% | Aug 28, 2025 |
| Rebecca Messina | Director | 33 | 0.00% | Aug 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Matthew K. Szot Director | Dec 4, 2025 | Other | −3 | – | – | 0 |
| Matthew K. Szot Director | Dec 3, 2025 | Sale | −4 | $1.52 | $6 | 3 |
| Trent D. Davis Director | Jun 1, 2022 | Buy | +11,184 | $0.95 | $10.62K | 33,622 |
| Barbara Ryan Director | Jun 1, 2022 | Buy | +10,526 | $0.95 | $10.00K | 22,991 |
| Michael Jos. Campbell Chief Operating Officer, Director | Jun 1, 2022 | Buy | +10,526 | $0.95 | $10.00K | 75,762 |
| Matthew K. Szot Director | Jun 1, 2022 | Buy | +14,474 | $0.95 | $13.75K | 39,175 |
| Kevin Doody Medical Director | Jun 1, 2022 | Buy | −177,306 | $0.95 | $168.44K | 0 |
| Rebecca Messina Director | Jun 1, 2022 | Buy | +9,868 | $0.95 | $9.37K | 23,045 |
| Andrea Goren Chief Financial Officer | Jun 1, 2022 | Buy | +52,632 | $0.95 | $50.00K | 129,015 |
| Jeffrey Segal Director | Jun 1, 2022 | Buy | +9,211 | $0.95 | $8.75K | 28,220 |
| Steve Shum Chief Executive Officer, Director | Jun 1, 2022 | Buy | +58,885 | $0.95 | $55.94K | 128,420 |
| Barbara Ryan Director | Jan 15, 2022 | Award | +8,588 | – | – | 21,053 |
| Kevin Doody Medical Director | Jan 15, 2022 | Award | +7,480 | – | – | 177,306 |
| Michael Jos. Campbell Chief Operating Officer, Director | Jan 15, 2022 | Award | +15,236 | – | – | 65,236 |
| Trent D. Davis Director | Jan 15, 2022 | Award | +8,865 | – | – | 22,438 |
| Jeffrey Segal Director | Jan 15, 2022 | Award | +8,034 | – | – | 18,009 |
| Rebecca Messina Director | Jan 15, 2022 | Award | +8,311 | – | – | 13,177 |
| Andrea Goren Chief Financial Officer | Jan 15, 2022 | Award | +5,361 | – | – | 17,861 |
| Matthew K. Szot Director | Jan 15, 2022 | Award | +10,250 | – | – | 24,701 |
| Steve Shum Chief Executive Officer, Director | Jan 15, 2022 | Award | +20,111 | – | – | 82,035 |
| Andrea Goren Chief Financial Officer | Oct 5, 2021 | Buy | +30,674 | $3.26 | $100.00K | 76,383 |
| Steve Shum Chief Executive Officer, Director | Oct 5, 2021 | Buy | +30,674 | $3.26 | $100.00K | 61,924 |
| Rebecca Messina Director | May 11, 2021 | Award | +4,806 | – | – | 4,806 |
| AWM Investment Company, Inc. 10% owner | May 10, 2021 | Buy | +1,000 | $3.76 | $3.76K | 1,159,075 |
| AWM Investment Company, Inc. 10% owner | May 6, 2021 | Buy | +1,000 | $3.85 | $3.85K | 1,158,075 |
| AWM Investment Company, Inc. 10% owner | May 4, 2021 | Buy | +2,457 | $3.85 | $9.46K | 1,157,075 |
| AWM Investment Company, Inc. 10% owner | May 4, 2021 | Buy | +465 | $3.85 | $1.79K | 1,154,618 |
| AWM Investment Company, Inc. 10% owner | Apr 27, 2021 | Buy | +3,800 | $4.44 | $16.87K | 1,154,153 |
| AWM Investment Company, Inc. 10% owner | Apr 20, 2021 | Buy | +3,500 | $3.90 | $13.65K | 1,150,353 |
| AWM Investment Company, Inc. 10% owner | Apr 19, 2021 | Buy | +5,801 | $3.64 | $21.12K | 1,146,853 |
| AWM Investment Company, Inc. 10% owner | Apr 16, 2021 | Buy | +9,001 | $3.83 | $34.47K | 1,141,052 |
| AWM Investment Company, Inc. 10% owner | Apr 15, 2021 | Buy | +322 | $3.85 | $1.24K | 1,132,051 |
| AWM Investment Company, Inc. 10% owner | Apr 14, 2021 | Buy | +17,152 | $3.95 | $67.75K | 1,131,729 |
| AWM Investment Company, Inc. 10% owner | Apr 13, 2021 | Buy | +5,800 | $3.97 | $23.03K | 1,114,577 |
| AWM Investment Company, Inc. 10% owner | Apr 12, 2021 | Buy | +13,146 | $4.00 | $52.58K | 1,108,777 |
| AWM Investment Company, Inc. 10% owner | Apr 9, 2021 | Buy | +27,811 | $4.08 | $113.47K | 1,095,631 |
| AWM Investment Company, Inc. 10% owner | Apr 8, 2021 | Buy | +15,000 | $4.08 | $61.20K | 1,067,820 |
| Trent D. Davis Director | Dec 31, 2020 | Award | +10,475 | – | – | 13,573 |
| Matthew K. Szot Director | Dec 31, 2020 | Award | +12,112 | – | – | 14,451 |
| Barbara Ryan Director | Dec 31, 2020 | Award | +10,148 | – | – | 12,465 |
| Kevin Doody Medical Director | Dec 31, 2020 | Award | +8,184 | – | – | 169,821 |
| Jeffrey Segal Director | Dec 31, 2020 | Award | +8,838 | – | – | 9,975 |
| Barbara Ryan Director | Nov 27, 2020 | Award | +2,317 | – | – | 2,317 |
| Jeffrey Segal Director | Nov 27, 2020 | Award | +1,137 | – | – | 1,137 |
| Matthew K. Szot Director | Nov 27, 2020 | Award | +2,339 | – | – | 2,339 |
| Michael Jos. Campbell Chief Operating Officer, Director | Jan 17, 2020 | Award | +1,000,000 | – | – | 1,607,800 |
| Steve Shum Chief Executive Officer, Director | Oct 16, 2019 | Award | +400,000 | – | – | 1,000,000 |
| Claude Ranoux 10% owner | Dec 3, 2018 | Discretionary | −1,000,000 | – | – | 25,194,000 |
| Claude Ranoux 10% owner | Dec 3, 2018 | Sale | −500,000 | $0.05 | $25.00K | 24,694,000 |
| Claude Ranoux 10% owner | Dec 3, 2018 | Discretionary | −1,000,000 | – | – | 25,194,000 |
| Claude Ranoux 10% owner | Dec 3, 2018 | Sale | −500,000 | $0.05 | $25.00K | 24,694,000 |
| Claude Ranoux 10% owner | Oct 31, 2018 | Award | +910,878 | – | – | 26,194,000 |
| Michael Jos. Campbell Director | Oct 31, 2018 | Award | +400,000 | $0.39 | $156.00K | 607,800 |
| Kathleen t. Karloff Chairwoman and CEO, Director | Oct 31, 2018 | Award | +1,040,183 | $0.39 | $405.67K | 13,200,183 |
| Steve Shum Director | Oct 31, 2018 | Award | +400,000 | $0.39 | $156.00K | 600,000 |
| Robert Joseph Bowdring Jr Director | Oct 31, 2018 | Award | +1,015,942 | $0.39 | $396.22K | 11,715,942 |
| Claude Ranoux 10% owner | Oct 31, 2018 | Award | +910,878 | $0.39 | $355.24K | 26,194,000 |
| Claude Ranoux 10% owner | Mar 5, 2018 | Sale | −12,642 | $0.19 | $2.40K | 25,283,122 |
| Claude Ranoux 10% owner | Mar 5, 2018 | Sale | −12,642 | $0.19 | $2.40K | 25,283,122 |
| Claude Ranoux 10% owner | Feb 28, 2018 | Sale | −2,000 | $0.18 | $360 | 25,296,764 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of INVO Fertility's stock actually held short. Settlement fails (shares not delivered on time) peaked at 30,088 shares on Aug 20, 2026 over the last 90 days.
See a number that looks wrong?